4.6 Article

Simultaneous determination of pramoxine HCl and benzalkonium chloride in wound care solutions by HPLC

期刊

ANALYTICAL METHODS
卷 2, 期 6, 页码 722-727

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/b9ay00284g

关键词

-

资金

  1. Johnson and Johnson, Group of Consumer Companies
  2. Sanofi-Aventis Foundation

向作者/读者索取更多资源

A simple gradient reversed-phase high performance liquid chromatography (H PLC) method was developed for the simultaneous determination of total benzalkonium chloride (BAC) and pramoxine HCl in wound care solutions. Laboratory formulations were diluted 1 10 with water and injected into a HPLC system equipped with a Phenomenex, Luna CN column (100 angstrom, 5 mu m, 250 mm x 4.6 mm) in order for BAC and pramoxine to separate from other excipients and be detected by a UV detector (lambda = 262 nm) The mobile phase was 0 075 mM sodium acetate trihydrate buffer (pH = 5 0) using multi-ramp gradient elution with acetonitrile Quantitation was achieved by direct comparison of the peaks of BAC and pramoxine HCl of the sample to a reference standard of known concentrations A stress study with acid, base, peroxide. heat, and light indicated no interference from drug product or excipients The mean recovery results for both pramoxine and benzalkonium chloride at 100% level were 100 5 +/- 03%. 100.5 +/- 0.1% respectively (mean +/- SD, n = 6). In this report, the full experimental results from developing and validating this method are presented

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据